Emiel J. Rutgers

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.”.

MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.506

N/A

0DataRank · unranked

65 citations

L. J. van ‘t Veer, Coralie Poncet, Josephine Lopes Cardozo, Suzette Delaloge, Jean‐Yves Pierga +15 more

EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy

European Journal of Cancer(2022)10.1016/j.ejca.2022.11.036

N/A

0DataRank · unranked

43 citations

J. Kelly, Anne Brédart, David Cameron, Jana de Boniface, Douglas F. Easton +9 more

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

Journal of Clinical Oncology(2023)10.1200/jco.22.01978

N/A

0DataRank · unranked

28 citations

Irene L. Andrulis, Stig E. Bojesen, Thilo Dörk, Diana Eccles, Peter A. Fasching +95 more